FTSE All-Share
4.647,52
PKT
+7,75
PKT
+0,17
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.01.23 | Prudential Buy | Deutsche Bank AG | |
| 10.01.23 | Rio Tinto Hold | Deutsche Bank AG | |
| 10.01.23 | Glencore Buy | Deutsche Bank AG | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 09.01.23 | GSK Equal Weight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 09.01.23 | GSK Sell | UBS AG | |
| 09.01.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 06.01.23 | GSK Neutral | Credit Suisse Group | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 06.01.23 | Unilever Buy | Jefferies & Company Inc. | |
| 06.01.23 | HSBC Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.01.23 | Glencore Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.01.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.01.23 | GSK Hold | Jefferies & Company Inc. | |
| 05.01.23 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.23 | Glencore Outperform | Credit Suisse Group | |
| 04.01.23 | Diageo Outperform | Credit Suisse Group | |
| 04.01.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | Diageo Buy | Goldman Sachs Group Inc. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 23.12.22 | GSK Equal Weight | Barclays Capital | |
| 21.12.22 | HSBC Outperform | RBC Capital Markets |